AIMA
TMO icon

Ables Iannone Moore & Associates’s Thermo Fisher Scientific TMO Stock Holding History

Ables Iannone Moore & Associates’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-101
Closed -$53.6K – 265
2023
Q4 		$53.6K Buy
+101
New +$48.9K 0.04% 94

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Ables Iannone Moore & Associates's TMO Position: Q1 2024 in Review

Ables Iannone Moore & Associates sold out of Thermo Fisher Scientific (TMO) in Q1 2024, closing a stake of 101 shares — an estimated $53.6K sold.

Ables Iannone Moore & Associates first reported a position in TMO in Q4 2023 and held it in 1 quarter. The position peaked at $53.6K in Q4 2023. 2,527 funds tracked by Wall St. Rank hold TMO as of Q1 2024.

  • Ables Iannone Moore & Associates reported no remaining Thermo Fisher Scientific position as of Q1 2024 after selling out during the quarter.
  • Ables Iannone Moore & Associates sold 101 Thermo Fisher Scientific shares in Q1 2024, an estimated $53.6K.
  • Ables Iannone Moore & Associates first reported a position in Thermo Fisher Scientific in Q4 2023 and held it in 1 quarter.
  • Ables Iannone Moore & Associates's Thermo Fisher Scientific position peaked at $53.6K in Q4 2023.
  • 2,527 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2024.

Based on Ables Iannone Moore & Associates's 13F filing for Q1 2024, filed 30 Apr 2024.